Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Diltiazem Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Tablet
  • 1.3.3 Capsule
  • 1.3.4 Injection
• 1.4 Market Segment by Application
  • 1.4.1 Global Diltiazem Market Share by Application (2019-2025)
  • 1.4.2 Angina
  • 1.4.3 Treating hypertension
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Diltiazem Market Size
  • 2.1.1 Global Diltiazem Revenue 2014-2025
  • 2.1.2 Global Diltiazem Sales 2014-2025
• 2.2 Diltiazem Growth Rate by Regions
  • 2.2.1 Global Diltiazem Sales by Regions 2014-2019
  • 2.2.2 Global Diltiazem Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Diltiazem Sales by Manufacturers
  • 3.1.1 Diltiazem Sales by Manufacturers 2014-2019
  • 3.1.2 Diltiazem Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Diltiazem Revenue by Manufacturers (2014-2019)
  • 3.2.2 Diltiazem Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Diltiazem Market Concentration Ratio (CR5 and HHI)
• 3.3 Diltiazem Price by Manufacturers
• 3.4 Key Manufacturers Diltiazem Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Diltiazem Market
• 3.6 Key Manufacturers Diltiazem Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Tablet Sales and Revenue (2014-2019)
  • 4.1.2 Capsule Sales and Revenue (2014-2019)
  • 4.1.3 Injection Sales and Revenue (2014-2019)
• 4.2 Global Diltiazem Sales Market Share by Type
• 4.3 Global Diltiazem Revenue Market Share by Type
• 4.4 Diltiazem Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Diltiazem Sales by Application

6 United States

• 6.1 United States Diltiazem Breakdown Data by Company
• 6.2 United States Diltiazem Breakdown Data by Type
• 6.3 United States Diltiazem Breakdown Data by Application

7 European Union

• 7.1 European Union Diltiazem Breakdown Data by Company
• 7.2 European Union Diltiazem Breakdown Data by Type
• 7.3 European Union Diltiazem Breakdown Data by Application

8 China

• 8.1 China Diltiazem Breakdown Data by Company
• 8.2 China Diltiazem Breakdown Data by Type
• 8.3 China Diltiazem Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Diltiazem Breakdown Data by Company
• 9.2 Rest of World Diltiazem Breakdown Data by Type
• 9.3 Rest of World Diltiazem Breakdown Data by Application
• 9.4 Rest of World Diltiazem Breakdown Data by Countries
  • 9.4.1 Rest of World Diltiazem Sales by Countries
  • 9.4.2 Rest of World Diltiazem Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Valeant Pharmaceuticals
  • 10.1.1 Valeant Pharmaceuticals Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Diltiazem
  • 10.1.4 Diltiazem Product Introduction
  • 10.1.5 Valeant Pharmaceuticals Recent Development
• 10.2 Teva
  • 10.2.1 Teva Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Diltiazem
  • 10.2.4 Diltiazem Product Introduction
  • 10.2.5 Teva Recent Development
• 10.3 Mylan
  • 10.3.1 Mylan Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Diltiazem
  • 10.3.4 Diltiazem Product Introduction
  • 10.3.5 Mylan Recent Development
• 10.4 Athenex
  • 10.4.1 Athenex Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Diltiazem
  • 10.4.4 Diltiazem Product Introduction
  • 10.4.5 Athenex Recent Development
• 10.5 Pfizer
  • 10.5.1 Pfizer Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Diltiazem
  • 10.5.4 Diltiazem Product Introduction
  • 10.5.5 Pfizer Recent Development
• 10.6 Akorn
  • 10.6.1 Akorn Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Diltiazem
  • 10.6.4 Diltiazem Product Introduction
  • 10.6.5 Akorn Recent Development
• 10.7 Sandoz
  • 10.7.1 Sandoz Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Diltiazem
  • 10.7.4 Diltiazem Product Introduction
  • 10.7.5 Sandoz Recent Development
• 10.8 Sun Pharma
  • 10.8.1 Sun Pharma Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Diltiazem
  • 10.8.4 Diltiazem Product Introduction
  • 10.8.5 Sun Pharma Recent Development
• 10.9 Hikma Pharmaceuticals
  • 10.9.1 Hikma Pharmaceuticals Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Diltiazem
  • 10.9.4 Diltiazem Product Introduction
  • 10.9.5 Hikma Pharmaceuticals Recent Development
• 10.10 Zydus Pharmaceuticals
  • 10.10.1 Zydus Pharmaceuticals Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Diltiazem
  • 10.10.4 Diltiazem Product Introduction
  • 10.10.5 Zydus Pharmaceuticals Recent Development
• 10.11 Par Pharmaceutical

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Diltiazem Sales Channels
  • 11.2.2 Diltiazem Distributors
• 11.3 Diltiazem Customers

12 Market Forecast

• 12.1 Global Diltiazem Sales and Revenue Forecast 2019-2025
• 12.2 Global Diltiazem Sales Forecast by Type
• 12.3 Global Diltiazem Sales Forecast by Application
• 12.4 Diltiazem Forecast by Regions
  • 12.4.1 Global Diltiazem Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Diltiazem Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Diltiazem is a nondihydropyridine (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, strength, and conduction speed of each beat.
In 2019, the market size of Diltiazem is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diltiazem.

This report studies the global market size of Diltiazem, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Diltiazem sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Valeant Pharmaceuticals
Teva
Mylan
Athenex
Pfizer
Akorn
Sandoz
Sun Pharma
Hikma Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceutical

Market Segment by Product Type
Tablet
Capsule
Injection

Market Segment by Application
Angina
Treating hypertension

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Diltiazem status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Diltiazem manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Diltiazem are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025